Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

19971,647 citationsJournal Articlebronze Open Access

Authors

Pierre D. Delmas · Inserm

Nina H. Bjarnason · Center for Clinical & Basic Research

Bruce Mitlak · Eli Lilly (United States)

Anne-Catherine Ravoux · Inserm

Aarti S. Shah · Eli Lilly (United States)

William J. Huster · Eli Lilly (United States)

Michael Draper ·

Abstract

Daily therapy with raloxifene increases bone mineral density, lowers serum concentrations of total and low-density lipoprotein cholesterol, and does not stimulate the endometrium.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 337, Issue 23, pp. 1641-1647

DOI: 10.1056/nejm199712043372301

Field-Weighted Citation Impact: 79.24